Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mark A. Meltz currently holds 50,000 shares of Kinnate Biopharma Inc. (KNTE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark A. Meltz has been a net neutral trader of KNTE stock. They have purchased $0 and sold $0 worth of shares.
Mark A. Meltz's most recent insider trade was on Feb 10, 2026, when they sold 50,000 shares at $0.00 per share.
Mark A. Meltz serves as Executive at Kinnate Biopharma Inc. (KNTE). They have executed 17 insider transactions totaling $0 over their tenure at the company.
Mark A. Meltz holds the position of Executive at Kinnate Biopharma Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Mark A. Meltz has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Mark A. Meltz was on Jan 15, 2020, when they sold $2.0M worth of BOLD shares. This transaction involved 32,705 shares at $60.00 per share.
Mark A. Meltz currently owns 50,000 shares of Kinnate Biopharma Inc. (KNTE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mark A. Meltz's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mark A. Meltz has 17 Form 4 filings on record as an insider at Kinnate Biopharma Inc..
Set alerts for Mark A. Meltz and 40,000+ other insiders.